Has TaiGen disclosed an FDA PDUFA date for its influenza drug TG-1000?
No FDA PDUFA date for TG-1000 was found in the TaiGen product and milestone pages checked on October 22, 2026. [1]
TaiGen’s milestone page records a China NDA submission in August 2024 and an FDA IND filing in October 2020. [1]
Dated evidence
| Claim | Value | As of | Source and original quotation |
|---|---|---|---|
| China regulatory filing | NDA submitted in mainland China in August 2024 | 2024-08 | Primary sourceA New Drug Application (NDA) |
| US regulatory filing | FDA IND filed in October 2020 | 2020-10 | Primary sourceTaiGen filed IND application |
Not disclosed in the public documents
The checked public company pages do not disclose a U.S. NDA acceptance or FDA review goal date for TG-1000. Document reviewed 2026-10-22
Pixavir (TG-1000)